Triple #12526

middle Confidence

Knowledge triple

RFS_5_year

Survival rate

Level 12

reported_as

Statistical relationship

94_percent

Survival rate

Level 12

Original triple: 5- and 10-year RFS rates#were reported as#94% and 78% respectively

Evidence and Confidence

Confidence: middle
Evidence Strength: clinical
Condition Dependency: not_specified
Fact or Inference: Fact

Clinical Relevance

Clinical Relevance: Prognostic significance

Other Info

PMID: 28719465
Knowledge Particle: KP4
Value Leadboard: 7
Disease: Adenoid cystic carcinoma